These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23190363)

  • 21. Minimally invasive therapy for renal cell carcinoma: is there a new community standard?
    Best S; Ercole B; Lee C; Fallon E; Skenazy J; Monga M
    Urology; 2004 Jul; 64(1):22-5. PubMed ID: 15245926
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiofrequency ablation of small renal tumors.
    Johnson DB; Cadeddu JA
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):77-83. PubMed ID: 14748659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical appraisal of the PADUA classification and assessment of the R.E.N.A.L. nephrometry score in patients undergoing partial nephrectomy.
    Hew MN; Baseskioglu B; Barwari K; Axwijk PH; Can C; Horenblas S; Bex A; Rosette JJ; Pes MP
    J Urol; 2011 Jul; 186(1):42-6. PubMed ID: 21571340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A critical analysis of the actual role of minimally invasive surgery and active surveillance for kidney cancer.
    Heuer R; Gill IS; Guazzoni G; Kirkali Z; Marberger M; Richie JP; de la Rosette JJ
    Eur Urol; 2010 Feb; 57(2):223-32. PubMed ID: 19853989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Russo P
    Eur Urol; 2010 Mar; 57(3):472-3. PubMed ID: 19359086
    [No Abstract]   [Full Text] [Related]  

  • 26. Editorial comment on: Positive surgical margin appears to have negligible impact on survival of renal cell carcinomas treated by nephron-sparing surgery.
    Eggener S
    Eur Urol; 2010 Mar; 57(3):472. PubMed ID: 19359087
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment of patients with small renal masses: a survey of the American Urological Association.
    Breau RH; Crispen PL; Jenkins SM; Blute ML; Leibovich BC
    J Urol; 2011 Feb; 185(2):407-13. PubMed ID: 21168170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Editorial comment.
    Uzzo RG
    J Urol; 2009 Nov; 182(5):2171. PubMed ID: 19758642
    [No Abstract]   [Full Text] [Related]  

  • 29. Rebuttal from authors re: Vincenzo Ficarra, Antonio Galfano and Stefano Cavalleri. Is simple enucleation a minimal partial nephrectomy responding to the EAU guidelines' recommendations? Eur Urol 2009;55:1315-8.
    Minervini A; Serni S; Di Cristofano C; Carini M
    Eur Urol; 2009 Jun; 55(6):1319-20. PubMed ID: 18804906
    [No Abstract]   [Full Text] [Related]  

  • 30. Editorial comment.
    Pomara G; Francesca F
    Urology; 2011 May; 77(5):1146; author reply 1146-7. PubMed ID: 21539964
    [No Abstract]   [Full Text] [Related]  

  • 31. Simultaneous laparoendoscopic single-site radical nephrectomy for native kidney and open nonischemic partial nephrectomy to treat concomitant renal cell carcinomas in native and transplant kidneys and to preserve allograft function.
    Sankari BR; Chueh SC
    Urology; 2012 Jan; 79(1):139-44. PubMed ID: 22055688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The multifocality problem in elective partial nephrectomy for renal-cell carcinoma].
    Cabezas CA; Fariña LA; Zungri ER
    Actas Urol Esp; 1999 Jan; 23(1):1-4. PubMed ID: 10089625
    [No Abstract]   [Full Text] [Related]  

  • 33. State-of-the-art surgical management of renal cell carcinoma.
    Thiel DD; Winfield HN
    Expert Rev Anticancer Ther; 2007 Sep; 7(9):1285-94. PubMed ID: 17892429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laparoscopic partial nephrectomy in the treatment of renal cell carcinoma: a minimally invasive means to nephron preservation.
    Blitstein J; Ghavamian R
    Expert Rev Anticancer Ther; 2008 Jun; 8(6):921-7. PubMed ID: 18533801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial comment to effect of number and location of distant metastases on renal cell carcinoma mortality in candidates for cytoreductive nephrectomy: implications for multimodal therapy.
    Gudbjartsson T
    Int J Urol; 2013 Jun; 20(6):579. PubMed ID: 23621609
    [No Abstract]   [Full Text] [Related]  

  • 36. Editorial comment.
    Herrell SD
    Urology; 2014 Feb; 83(2):506-7. PubMed ID: 24468518
    [No Abstract]   [Full Text] [Related]  

  • 37. Perioperative outcomes of robotic-assisted partial nephrectomy in elderly patients: a matched-cohort study.
    Hillyer SP; Autorino R; Spana G; Guillotreau J; Stein RJ; Haber GP; Kaouk JH
    Urology; 2012 May; 79(5):1063-7. PubMed ID: 22546384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The surgical approach to multifocal renal cancers: hereditary syndromes, ipsilateral multifocality, and bilateral tumors.
    Shuch B; Singer EA; Bratslavsky G
    Urol Clin North Am; 2012 May; 39(2):133-48, v. PubMed ID: 22487757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Usefulness of R.E.N.A.L. nephrometry scoring system for predicting outcomes and complications of percutaneous ablation of 751 renal tumors.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Boorjian SA; Carter RE; Geske JR; Callstrom MR; Atwell TD
    J Urol; 2013 Jan; 189(1):30-5. PubMed ID: 23164375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Developments in kidney tumor nephrometry.
    Lieser G; Simmons MN
    Postgrad Med; 2011 May; 123(3):35-42. PubMed ID: 21566414
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.